The LUNGevity Foundation has awarded a 2014 Career Development Award for Translational Research to Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology.

A new study estimates that tobacco smoking has been linked to approximately 2 million deaths among adult men and women in Asia in recent years and predicts a rising death toll.

Researchers at Vanderbilt University have identified a potential new drug target in subtypes of lung cancer that are difficult to treat.

Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer.

Vanderbilt-Ingram Cancer Center has launched a new lung cancer screening program to provide low-dose CT scans for patients at high risk for the deadly disease. Current or former smokers ages 55 to 74 who have a history of 30 or more pack years of smoking are eligible for the scans.

Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.

Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.